Engerix-B Related Clinical Trials
Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections [Active, not recruiting]
Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine [Active, not recruiting]
Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B [Completed]
Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients [Completed]
Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules [Completed]
Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B [Completed]
Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders [Completed]
Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults [Completed]
Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents [Completed]
Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-Responder Population ≥ 15y [Completed]
Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years [Completed]
Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y [Completed]
Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-Blind Safety Evaluation Using Engerix™-B as Control [Completed]
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults [Completed]
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs). [Completed]
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y [Completed]
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y [Completed]
Comparison of DTaP IPV HB PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV [Active, not recruiting]
Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine. [Completed]
Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine [Recruiting]
Hepatitis B Vaccine Booster Study [Recruiting]
Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years [Completed]
Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine. [Not yet recruiting]
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-Liver Transplant Patients 18 Years of Age [Completed]
Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years [Completed]
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype [Completed]
Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients? [Recruiting]
Immunologic Memory (Supp. of ATN 024) [Completed]
Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge [Completed]
Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 Administered in Healthy Adolescents. [Recruiting]
Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants [Completed]
Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults [Completed]
Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine [Completed]
Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth [Active, not recruiting]
Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine [Completed]
Immuno & Safety Study of GSK Biologicals’ Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs [Active, not recruiting]
Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response [Completed]
Long-Term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination. [Completed]
Immunogenicity of DTaP-IPV-HB-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule [Active, not recruiting]
A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-Old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA [Recruiting]
A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321 [Completed]
Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients [Completed]
Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine co-Administered With Another Vaccine in Healthy Female Subjects [Recruiting]
Study to Show That the Combined Hepatitis A and B Vaccine is Non-Inferior to Monovalent Vaccines in Adults [Recruiting]
Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine. [Recruiting]
Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination [Not yet recruiting]
Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults [Active, not recruiting]
Hepatitis B Vaccine Predialysis/Dialysis Study [Active, not recruiting]
Modified Process Hepatitis B Vaccine Administered to Healthy Infants at 2, 4 and 6 Months of Age [Active, not recruiting]
Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-Stage Kidney Failure Patients [Active, not recruiting]
Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants [Active, not recruiting]
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals
A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso [Recruiting]
|
